Last reviewed · How we verify
Ferric Trihydroxide — Competitive Intelligence Brief
phase 2
ferric hydroxide
Gastroenterology
Small molecule
Live · refreshed every 30 min
Target snapshot
Ferric Trihydroxide (FERRIC HYDROXIDE). Ferric Trihydroxide works by binding to iron in the body, potentially helping to remove excess iron and alleviate associated conditions.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Ferric Trihydroxide TARGET | FERRIC HYDROXIDE | phase 2 | ferric hydroxide |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (ferric hydroxide class)
- · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Ferric Trihydroxide CI watch — RSS
- Ferric Trihydroxide CI watch — Atom
- Ferric Trihydroxide CI watch — JSON
- Ferric Trihydroxide alone — RSS
- Whole ferric hydroxide class — RSS
Cite this brief
Drug Landscape (2026). Ferric Trihydroxide — Competitive Intelligence Brief. https://druglandscape.com/ci/ferric-hydroxide. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing